Professional Overview

Felipe Lino is a seasoned technology executive currently serving as the CTO and co-founder at Nosh.bio GmbH in Berlin, Germany. His expertise spans biotechnology, bio-ingredients, and research and development, with a strong focus on the biotechnology industry.

Experience Summary

Current Role

Felipe Lino is currently the CTO and co-founder at Nosh.bio GmbH, a position he has held since February 2022. As CTO, he oversees the technical strategy and direction of the company, driving innovation and growth in the biotechnology sector.

Career Progression

Prior to his current role, Felipe held various notable positions, including Entrepreneur in Residence and Cofounder at StealthCo at EVIG Group, Global R&D Project Manager at Anheuser-Busch InBev, and PostDoc and PhD Student at The Novo Nordisk Foundation Center for Biosustainability. He also worked as a Research Associate at Novozymes and provided consultancy services to biotechnology start-ups.

Academic Background

Felipe holds a PhD in Biotechnology from The Novo Nordisk Foundation Center for Biosustainability and an MSc in Biotechnology from the University of São Paulo.

Areas of Expertise

Felipe's expertise includes biotechnology, bio-ingredients, research and development, project management, and technical leadership. He possesses strong technical competencies, including experience with biotechnology research, development, and innovation.

Professional Impact

Although specific project details are not available, Felipe's experience in driving technical strategy and overseeing research and development projects has likely contributed to the growth and innovation of the companies he has worked with.

Conclusion

Felipe Lino's professional trajectory demonstrates a strong focus on biotechnology, research, and development. As the current CTO and co-founder at Nosh.bio GmbH, he continues to drive innovation and growth in the biotechnology sector. With his technical expertise, leadership capabilities, and experience in research and development, Felipe offers a unique value proposition as a seasoned technology executive in the biotechnology industry.